Efudix
Efudix is a medicine authorised by Swissmedic under authorisation number 36464. The authorisation holder is MEDA Pharmaceuticals Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 16 July 1971 and the authorisation is valid without a time limit. ATC code L01BC02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 36464 |
|---|---|
| Name | Efudix |
| Full name | Efudix, Crème |
| Authorisation holder | MEDA Pharmaceuticals Switzerland GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BC02 |
| First authorisation | 16 July 1971 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Efudix, Crème | A | 16 July 1971 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 20 | g | L01BC02 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Efudix authorised in Switzerland?
Yes. Efudix is authorised by Swissmedic under authorisation number 36464, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Efudix have?
Efudix is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Efudix?
The authorisation holder is MEDA Pharmaceuticals Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.